Fund shareholders of Stoke Therapeutics Inc
ISIN US86150R1077 · United States · LEI 549300RD25SS2DIJHJ67
- Fund shareholders
- 231
- Of which ETFs
- 55 176 other funds
- Value held
- 623.7M $
- Share of capital
- 29.0 % of 64.5M shares on Jul 30, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| SA Franklin Tactical Opportunities Portfolio SUNAMERICA SERIES TRUST | 761 | 24.9K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Putnam VT Global Asset Allocation Fund Putnam Variable Trust | 703 | 22.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 679 | 24.7K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Eventide Small Cap ETF Strategy Shares | 623 | 20.4K $ | 0.08 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 622 | 20.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| WisdomTree U.S. SmallCap Quality Growth Fund WisdomTree Trust | 613 | 20K $ | 0.20 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 552 | 18.1K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 534 | 17.5K $ | 0.11 % | 0.00 % | as of Apr 30, 2026 ↗ |
| American Century Small Cap Growth Insights ETF American Century ETF Trust | 520 | 18.9K $ | 0.21 % | 0.00 % | as of Feb 28, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 519 | 16.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| EQ/Common Stock Index Portfolio EQ Advisors Trust | 500 | 16.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Sustainable U.S. Market Fund Fidelity Summer Street Trust | 426 | 13.9K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional US Sustainability Core 1 ETF Dimensional ETF Trust | 407 | 13.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| U.S. Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 400 | 13.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Marketwide Value ETF Dimensional ETF Trust | 341 | 11.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 296 | 9.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 263 | 8.6K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 258 | 8.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 240 | 7.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 190 | 6.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 184 | 6K $ | 0.08 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 164 | 5.3K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 124 | 4K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 110 | 3.6K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 89 | 2.9K $ | 0.04 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 66 | 2.1K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 48 | 1.6K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 46 | 1.7K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 15 | 546.2 $ | 0.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 13 | 423.3 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Longview Advantage ETF RBB Fund Trust | 11 | 400.5 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| WisdomTree BioRevolution Fund WisdomTree Trust | 2.53 % | as of Mar 31, 2026 ↗ |
| First Trust Dow Jones Select MicroCap Index Fund First Trust Exchange-Traded Fund | 2.35 % | as of Mar 31, 2026 ↗ |
| Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 1.60 % | as of Mar 31, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 1.50 % | as of Feb 28, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.34 % | as of Feb 28, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 0.91 % | as of Apr 30, 2026 ↗ |
| Harbor Active Small Cap Growth ETF Harbor ETF Trust | 0.90 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.75 % | as of Apr 30, 2026 ↗ |
| HUSSMAN STRATEGIC MARKET CYCLE FUND Hussman Investment Trust | 0.66 % | as of Mar 31, 2026 ↗ |
| First Trust Small Cap Growth AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 0.56 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 231 | +23 | 18,702,906 | +16.5 % |
| 2026Q1 | 208 | +35 | 16,048,338 | +6.3 % |
| 2025Q4 | 173 | +20 | 15,092,342 | +0.1 % |
| 2025Q3 | 153 | +5 | 15,077,610 | +27.5 % |
| 2025Q2 | 148 | +14 | 11,829,261 | +32.7 % |
| 2025Q1 | 134 | -4 | 8,911,056 | -3.1 % |
| 2024Q4 | 138 | +6 | 9,196,244 | +0.3 % |
| 2024Q3 | 132 | +14 | 9,166,785 | +112.1 % |
| 2024Q2 | 118 | -1 | 4,322,072 | -3.2 % |
| 2024Q1 | 119 | -7 | 4,463,278 | -4.8 % |
| 2023Q4 | 126 | 4,688,442 |
Institutional managers
190 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,623,525 | 183.1M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,385,714 | 175.4M $ | as of Mar 31, 2026 |
| FMR LLC | 5,383,666 | 175.3M $ | as of Mar 31, 2026 |
| Lynx1 Capital Management LP | 4,763,673 | 155.1M $ | as of Mar 31, 2026 |
| Redmile Group, LLC | 4,164,120 | 135.6M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 3,423,280 | 111.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 3,336,697 | 108.6M $ | as of Mar 31, 2026 |
| TORONTO DOMINION BANK | 3,173,258 | 103.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 3,095,700 | 100.8M $ | as of Mar 31, 2026 |
| BVF INC/IL | 2,547,557 | 82.9M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,276,512 | 74.1M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 1,995,347 | 65M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,934,171 | 63K $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1,823,500 | 59.4M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 1,612,781 | 52.5M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,322,260 | 43.1M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 1,132,511 | 36.9M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 989,936 | 32.2M $ | as of Mar 31, 2026 |
| Assenagon Asset Management S.A. | 907,015 | 29.5M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 830,702 | 27M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 767,038 | 25M $ | as of Mar 31, 2026 |
| Opaleye Management Inc. | 700,000 | 22.8M $ | as of Mar 31, 2026 |
| Troluce Capital Advisors LLC | 652,800 | 21.3M $ | as of Mar 31, 2026 |
| BAILLIE GIFFORD & CO | 575,182 | 18.7M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 543,095 | 17.7M $ | as of Mar 31, 2026 |
Declared shareholders of Stoke Therapeutics Inc
There are 5 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| RTW Investments, LP and 1 other | 9.90 % | 5,940,866 | as of Mar 31, 2026 · SCHEDULE 13G |
| Lynx1 Capital Management LP and 1 other | 8.10 % | 4,763,673 | as of Mar 31, 2026 · SCHEDULE 13G |
| Redmile Group, LLC and 2 others | 6.70 % | 4,164,120 | as of Mar 31, 2026 · SCHEDULE 13G |
| The Toronto-Dominion Bank and 1 other | 5.40 % | 3,173,258 | as of Mar 31, 2026 · SCHEDULE 13G |
| Wellington Management Group LLP and 3 others | 5.20 % | 3,095,700 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Stoke Therapeutics Inc". https://titelia.com/en/stocks/stoke-therapeutics-inc-US86150R1077